7-150959602-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_000238.4(KCNH2):​c.442C>T​(p.Arg148Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000801 in 1,614,080 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R148Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00064 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00082 ( 7 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

4
8
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:14O:1

Conservation

PhyloP100: 2.88

Publications

24 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 158 curated pathogenic missense variants (we use a threshold of 10). The gene has 38 curated benign missense variants. Gene score misZ: 3.3724 (above the threshold of 3.09). Trascript score misZ: 2.4846 (below the threshold of 3.09). GenCC associations: The gene is linked to long QT syndrome 2, Brugada syndrome, short QT syndrome type 1, short QT syndrome, long QT syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.012147158).
BP6
Variant 7-150959602-G-A is Benign according to our data. Variant chr7-150959602-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 67505.
BS2
High AC in GnomAd4 at 98 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.442C>Tp.Arg148Trp
missense
Exon 3 of 15NP_000229.1A0A090N8Q0
KCNH2
NM_001406753.1
c.154C>Tp.Arg52Trp
missense
Exon 1 of 13NP_001393682.1Q12809-7
KCNH2
NM_172056.3
c.442C>Tp.Arg148Trp
missense
Exon 3 of 9NP_742053.1Q12809-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.442C>Tp.Arg148Trp
missense
Exon 3 of 15ENSP00000262186.5Q12809-1
KCNH2
ENST00000713710.1
c.442C>Tp.Arg148Trp
missense
Exon 3 of 15ENSP00000519013.1A0AAQ5BGR0
KCNH2
ENST00000713701.1
c.142C>Tp.Arg48Trp
missense
Exon 2 of 14ENSP00000519004.1A0AAQ5BGQ9

Frequencies

GnomAD3 genomes
AF:
0.000644
AC:
98
AN:
152154
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00122
AC:
307
AN:
250940
AF XY:
0.00110
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.0162
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000627
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.000817
AC:
1195
AN:
1461808
Hom.:
7
Cov.:
32
AF XY:
0.000814
AC XY:
592
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000358
AC:
16
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0151
AC:
394
AN:
26134
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39700
South Asian (SAS)
AF:
0.00112
AC:
97
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.000511
AC:
568
AN:
1111976
Other (OTH)
AF:
0.00157
AC:
95
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
74
149
223
298
372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000644
AC:
98
AN:
152272
Hom.:
0
Cov.:
33
AF XY:
0.000551
AC XY:
41
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41550
American (AMR)
AF:
0.0000654
AC:
1
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
44
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000573
AC:
39
AN:
68016
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00128
Hom.:
4
Bravo
AF:
0.000767
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00105
AC:
128
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.000948

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (7)
-
2
2
Long QT syndrome (4)
-
2
2
not specified (4)
-
-
2
Long QT syndrome 2 (2)
-
-
1
Cardiac arrhythmia (1)
-
-
1
Cardiovascular phenotype (1)
-
1
-
Conduction disorder of the heart (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Uncertain
0.034
T
BayesDel_noAF
Pathogenic
0.25
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
D
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.031
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.85
T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.012
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
1.7
L
PhyloP100
2.9
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.6
D
REVEL
Pathogenic
0.74
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.044
D
Polyphen
1.0
D
Vest4
0.33
MVP
0.95
MPC
1.0
ClinPred
0.044
T
GERP RS
3.8
Varity_R
0.23
gMVP
0.61
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139544114; hg19: chr7-150656690; API